Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Insmed Inc

NASDAQ: INSM · Life Sciences · 4 alerts · CIK 1104506

Share price
$122.88Close, Nov 16
Market cap
$27B
Shares outstanding
219.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Insmed Inc filings on SEC EDGAR ↗

7:01 AM ET 8-K
Leadership Change

Insmed Leadership Change

Insmed Incorporated appointed Paul Hudson, former CEO of Sanofi and Novartis, and Utpal Koppikar, CFO of Verily Health, to its Board of Directors effective October 19, 2026. Both directors will receive an annual cash retainer of $65,000 plus committee fees and an initial RSU grant valued at approximately $585,000. The appointments add significant global biopharma leadership and financial expertise to the board as the company advances its rare disease pipeline.

7:01 AM ET 8-K
Leadership Change

Insmed Leadership Change

Sara Bonstein is stepping down as Chief Financial Officer of Insmed, effective October 30, 2026, to pursue a broader leadership role. The company has initiated a search for a successor and reaffirmed its full-year 2026 revenue guidance for BRINSUPRI and ARIKAYCE.

Earnings call
Oct 29, 2026, 8:00 AM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.